| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Evans Carl Anthony serves as a Director at CNSP. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $184K at current prices.
The biggest single holding is CNSP (~$184K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 33,333 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | CNSP Cns Pharmaceuticals, Inc. | Director | Buy | 33,333 | $0.30 | $9,999.90 | +26,666% | -13.7% | -99.2% |